Print this page

Screening Protocol for Clinical Trial Eligibility.

To permit evaluation of patients referred to the Cancer Institute in order to identify individuals who will be suitable candidates for cellular therapy protocol by testing blood and tumor tissue for expression of different antigens.

Protocol Number: 192101
Phase: N/A
Applicable Disease Sites: Any Site
Principal Investigator: Christian Hinrichs
Scope: Local
Participating Institutions:
  • RWJBarnabas Health
    • Community Medical Center
    • Cooperman Barnabas, Livingston
    • Jersey City Medical Center, Jersey City
    • Monmouth Medical Center
    • Monmouth Medical Center Southern Campus
    • Newark Beth Israel Medical Center
    • Robert Wood Johnson University Hospital, Hamilton
    • Robert Wood Johnson University Hospital, Somerset
    • Trinitas Hospital and Comprehensive Cancer Center
  • Rutgers University

For further information about clinical trials, please contact us at 732-235-7356.